leading glp-1 treatments for diabetes 2025 Pipeline Update: August - Prime Therapeutics Poll: 1 in 8 Adults

They were originally developed for management of type 2 diabetes, but have since become a common treatment for weight management within the UK

Confirmatory large-scale trials are essential to ascertain the potential efficacy of GLP-1RAs in specifically improving the stroke outcomes

These experiences, while not universal, suggest that the refund process could be more patient-friendly

Thats why we focus on all aspects of your health at our weight loss clinic, because its not just about the number on the scale

Curb cravings and regulate appetite*

Although experimental studies suggest potential pancreatic harm from GLP-1 RAs, robust clinical evidence demonstrates that these drugs do not increase the incidence of pancreatitis or pancreatic cancer in diverse human populations